HARTFORD, Conn.--(BUSINESS WIRE)-- Aetna (NYSE: AET) today announced that first-quarter 2018 results will be made public on Tuesday, May 1, at 6:30 a.m. ET. Given the pending transaction with CVS Health, Aetna will not host a conference call in conjunction with its earnings release and does not expect to do so for future quarters.

Effective for the first quarter of 2018, Aetna realigned its business segments to correspond with changes to its management structure and internal management reporting, which reflect the company's evolving business strategy of helping its members live healthier lives. As a result of this realignment, Aetna’s operations will now be conducted in the Health Care reportable segment. Health Care offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services to large and small employers, public sector employers, and Medicaid and Medicare beneficiaries. Aetna’s Health Care products are offered on both an insured basis and an employer-funded basis. Health Care also includes emerging business products and services that complement and enhance Aetna's medical products.

Effective for the first quarter of 2018, Aetna will present the remainder of its financial results in the Corporate/Other category, which will consist of:

• Products for which Aetna no longer solicits or accepts new customers, such as its large case pensions and long-term care products;
• Contracts Aetna has divested through reinsurance or other contracts, such as its domestic group life insurance, group disability insurance and absence management businesses; and
• Corporate expenses not supporting Aetna’s business operations, including transaction and integration-related costs, income taxes, interest expense on its outstanding debt and the financing components of its pension and other postretirement employee benefit plans expense.

Restated historical financial statements of income before income taxes attributable to Aetna by segment and total company and certain other financial measures for each quarter of 2017 and full year 2017 are included with this press release. Aetna presents both GAAP and non-GAAP financial measures in this press release to provide investors with additional information. Refer to footnotes (1) and (2) for definitions of non-GAAP financial measures and pages 3 through 5 for reconciliations of the most directly comparable GAAP financial measures to non-GAAP financial measures.

About AetnaAetna is one of the nation's leading diversified health care benefits companies, serving an estimated 37.9 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, and medical management capabilities, Medicaid health care management services, workers' compensation administrative services and health information technology products and services. Aetna's customers include employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups and expatriates. For more information, see www.aetna.com and learn about how Aetna is helping to build a healthier world. @AetnaNews

Statements of Income Before Income Taxes Attributable to Aetna by Segment (Unaudited)
				Health Care
(Millions)				Q1 2017					Q2 2017					Q3 2017					Q4 2017					Full Year 2017
Revenue:
Premiums				$	13,240				$	13,242				$	12,730				$	12,890				$	52,102
Fees and other revenue				1,448					1,458					1,416					1,428					5,750
Net investment income				117					114					113					138					482
Net realized capital gains				1					7					26					21					55
Total revenue				14,806					14,821					14,285					14,477					58,389
Benefits and expenses:
Benefit costs				10,928					10,591					10,423					10,862					42,804
Operating expenses				2,625					2,472					2,521					2,934					10,552
Amortization of other acquired intangible assets				60					58					58					96					272
Total benefits and expenses				13,613					13,121					13,002					13,892					53,628
Income before income taxes including non-controlling interests				1,193					1,700					1,283					585					4,761
Less: Income (loss) before income taxes attributable to non-controlling interests				2					(23		)			14					(4		)			(11		)
Income before income taxes attributable to Aetna				$	1,191				$	1,723				$	1,269				$	589				$	4,772

Reconciliation of the Most Directly Comparable GAAP Measure to Certain Reported Amounts
(Millions)				Health Care
Reconciliation of total revenue to adjusted revenue				Q1 2017					Q2 2017					Q3 2017					Q4 2017					Full Year 2017
Total revenue (GAAP measure)				$	14,806				$	14,821				$	14,285				$	14,477				$	58,389
Net realized capital gains				(1		)			(7		)			(26		)			(21		)			(55		)
Adjusted revenue(2) (excludes net realized capital gains)				$	14,805				$	14,814				$	14,259				$	14,456				$	58,334
Reconciliation of income before income taxes to pre-tax adjusted earnings
Income before income taxes (GAAP measure)				$	1,193				$	1,700				$	1,283				$	585				$	4,761
Less: Income (loss) before income taxes attributable to non-controlling interests (GAAP measure)				2					(23		)			14					(4		)			(11		)
Income before income taxes attributable to Aetna (GAAP measure)				1,191					1,723					1,269					589					4,772
Penn Treaty-related guaranty fund assessments				231					—					—					—					231
Amortization of other acquired intangible assets				60					58					58					96					272
Net realized capital gains				(1		)			(7		)			(26		)			(21		)			(55		)
Pre-tax adjusted earnings(1)				$	1,481				$	1,774				$	1,301				$	664				$	5,220

Statements of Income Before Income Taxes Attributable to Aetna by Segment (Unaudited)
				Corporate/Other (3)
(Millions)				Q1 2017					Q2 2017					Q3 2017					Q4 2017					Full Year 2017
Revenue:
Premiums				$	523				$	533				$	542				$	194				$	1,792
Fees and other revenue				27					28					27					98					180
Net investment income				143					123					120					82					468
Net realized capital (losses) gains				(334		)			18					20					2					(294		)
Total revenue				359					702					709					376					2,146
Benefits and expenses:
Benefit costs				533					525					537					229					1,824
Operating expenses				1,228					80					91					113					1,512
Interest expense				173					86					90					93					442
Loss on early extinguishment of long-term debt				246					—					—					—					246
Reduction of reserve for anticipated future losses on discontinued products				—					(109		)			—					—					(109		)
Total benefits and expenses				2,180					582					718					435					3,915
(Loss) income before income taxes including non-controlling interests				(1,821		)			120					(9		)			(59		)			(1,769		)
Less: Income before income taxes attributable to non-controlling interests				1					—					—					—					1
(Loss) income before income taxes attributable to Aetna				$	(1,822	)			$	120				$	(9	)			$	(59	)			$	(1,770	)

Reconciliation of the Most Directly Comparable GAAP Measure to Certain Reported Amounts
(Millions)				Corporate/Other (3)
Reconciliation of total revenue to adjusted revenue				Q1 2017				Q2 2017				Q3 2017				Q4 2017				Full Year 2017
Total revenue (GAAP measure)				$	359			$	702			$	709			$	376			$	2,146
Gain related to sale of certain domestic group insurance businesses				—				—				—				(88		)		(88		)
Interest income on proceeds of transaction-related debt				(11		)		—				—				—				(11		)
Net realized capital losses (gains)				334				(18		)		(20		)		(2		)		294
Adjusted revenue(2) (excludes net realized capital losses (gains) and other items)				$	682			$	684			$	689			$	286			$	2,341
Reconciliation of income before income taxes to pre-tax adjusted loss
(Loss) income before income taxes (GAAP measure)				$	(1,821	)		$	120			$	(9	)		$	(59	)		$	(1,769	)
Less: Income before income taxes attributable to non-controlling interests (GAAP measure)				1				—				—				—				1
(Loss) income before income taxes attributable to Aetna (GAAP measure)				(1,822		)		120				(9		)		(59		)		(1,770		)
Gain related to sale of certain domestic group insurance businesses				—				—				—				(88		)		(88		)
Loss on early extinguishment of long-term debt				246				—				—				—				246
Transaction and integration-related costs				1,212				(10		)		—				38				1,240
Restructuring costs				—				—				—				60				60
Reduction of reserve for anticipated future losses on discontinued products				—				(109		)		—				—				(109		)
Net realized capital losses (gains)				334				(18		)		(20		)		(2		)		294
Pre-tax adjusted loss(1)				$	(30	)		$	(17	)		$	(29	)		$	(51	)		$	(127	)

Statements of Income Before Income Taxes Attributable to Aetna (Unaudited)
				Total Company
(Millions)				Q1 2017					Q2 2017					Q3 2017					Q4 2017					Full Year 2017
Revenue:
Premiums				$	13,763				$	13,775				$	13,272				$	13,084				$	53,894
Fees and other revenue				1,475					1,486					1,443					1,526					5,930
Net investment income				260					237					233					220					950
Net realized capital (losses) gains				(333		)			25					46					23					(239		)
Total revenue				15,165					15,523					14,994					14,853					60,535
Benefits and expenses:
Benefit costs				11,461					11,116					10,960					11,091					44,628
Operating expenses				3,853					2,552					2,612					3,047					12,064
Interest expense				173					86					90					93					442
Loss on early extinguishment of long-term debt				246					—					—					—					246
Amortization of other acquired intangible assets				60					58					58					96					272
Reduction of reserve for anticipated future losses on discontinued products				—					(109		)			—					—					(109		)
Total benefits and expenses				15,793					13,703					13,720					14,327					57,543
(Loss) income before income taxes including non-controlling interests				(628		)			1,820					1,274					526					2,992
Less: Income (loss) before income taxes attributable to non-controlling interests				3					(23		)			14					(4		)			(10		)
(Loss) income before income taxes attributable to Aetna				$	(631	)			$	1,843				$	1,260				$	530				$	3,002

Reconciliation of the Most Directly Comparable GAAP Measure to Certain Reported Amounts
(Millions)				Total Company
Reconciliation of total revenue to adjusted revenue				Q1 2017					Q2 2017					Q3 2017					Q4 2017					Full Year 2017
Total revenue (GAAP measure)				$	15,165				$	15,523				$	14,994				$	14,853				$	60,535
Gain related to sale of certain domestic group insurance businesses				—					—					—					(88		)			(88		)
Interest income on proceeds of transaction-related debt				(11		)			—					—					—					(11		)
Net realized capital losses (gains)				333					(25		)			(46		)			(23		)			239
Adjusted revenue(2) (excludes net realized capital losses (gains) and other items)				$	15,487				$	15,498				$	14,948				$	14,742				$	60,675
Reconciliation of income before income taxes to pre-tax adjusted earnings
(Loss) income before income taxes (GAAP measure)				$	(628	)			$	1,820				$	1,274				$	526				$	2,992
Less: Income (loss) before income taxes attributable to non-controlling interests (GAAP measure)				3					(23		)			14					(4		)			(10		)
(Loss) income before income taxes attributable to Aetna (GAAP measure)				(631		)			1,843					1,260					530					3,002
Gain related to sale of certain domestic group insurance businesses				—					—					—					(88		)			(88		)
Loss on early extinguishment of long-term debt				246					—					—					—					246
Penn Treaty-related guaranty fund assessments				231					—					—					—					231
Transaction and integration-related costs				1,212					(10		)			—					38					1,240
Restructuring costs				—					—					—					60					60
Reduction of reserve for anticipated future losses on discontinued products				—					(109		)			—					—					(109		)
Amortization of other acquired intangible assets				60					58					58					96					272
Net realized capital losses (gains)				333					(25		)			(46		)			(23		)			239
Pre-tax adjusted earnings(1)				$	1,451				$	1,757				$	1,272				$	613				$	5,093

Health Care Medical Benefit Ratios
(Millions)				Q1 2017					Q2 2017					Q3 2017					Q4 2017					Full Year 2017
Premiums (GAAP measure)
Commercial				$	6,129				$	6,287				$	6,063				$	6,149				$	24,628
Government				7,111					6,955					6,667					6,741					27,474
Health Care				$	13,240				$	13,242				$	12,730				$	12,890				$	52,102
Health Care Costs (GAAP measure)
Commercial				$	4,860				$	4,938				$	4,928				$	5,277				$	20,003
Government				6,068					5,653					5,495					5,585					22,801
Health Care				$	10,928				$	10,591				$	10,423				$	10,862				$	42,804
Medical Benefit Ratios "MBRs"
Commercial				79.3		%			78.5		%			81.3		%			85.8		%			81.2		%
Government				85.3		%			81.3		%			82.4		%			82.9		%			83.0		%
Health Care				82.5		%			80.0		%			81.9		%			84.3		%			82.2		%

Footnotes

(1) Non-GAAP financial measures such as pre-tax adjusted earnings (loss) and adjusted revenue exclude from the relevant GAAP metrics, as applicable:

• Amortization of other acquired intangible assets;
• Net realized capital gains or losses; and
• Other items, if any, that neither relate to the ordinary course of Aetna's business nor reflect Aetna's underlying business performance.

Although the excluded items may recur, management believes that non-GAAP financial measures Aetna discloses, including those described above, provide a more useful comparison of Aetna's underlying business performance from period to period. The chief executive officer assesses consolidated Aetna results based on adjusted earnings and assesses business segment results based on pre-tax adjusted earnings because income taxes are recorded in Aetna’s Corporate/Other segment and are not allocated to Aetna’s business operations. The non-GAAP financial measures Aetna discloses, including those described above, should not be considered a substitute for, or superior to, financial measures determined or calculated in accordance with GAAP.

For the periods covered in this press release, the following items are excluded from the non-GAAP financial measures described above, as applicable, because Aetna believes they neither relate to the ordinary course of Aetna's business nor reflect Aetna's underlying business performance:

• During the three months ended December 31, 2017, Aetna sold its domestic group life insurance, group disability insurance and absence management businesses (the "Group Insurance sale"). The transaction was accomplished through an indemnity reinsurance arrangement. A significant portion of the gain has been deferred and will be amortized into earnings: (a) over the remaining contract period (estimated to be approximately 3 years) in proportion to the amount of insurance protection provided for the prospective reinsurance portion of the gain and (b) as Aetna recovers amounts due from the buyer over a period estimated to be approximately 30 years for the retrospective reinsurance portion of the gain. The gain recognized does not directly relate to the underwriting or servicing of products for customers and is not directly related to the core performance of Aetna's business operations.
• During the three months ended March 31, 2017, Aetna incurred losses on the early extinguishment of long-term debt due to (a) the mandatory redemption of $10.2 billion aggregate principal amount of certain of its senior notes issued in June 2016 (collectively, the "SMR Notes") following the termination of the definitive agreement (the "Humana Merger Agreement") to acquire Humana Inc. ("Humana") and (b) the early redemption of $750 million aggregate principal amount of its outstanding senior notes due 2020.
• During the three months ended March 31, 2017, Aetna recorded an expense for estimated future guaranty fund assessments related to Penn Treaty Network America Insurance Company and one of its subsidiaries (collectively, "Penn Treaty"), which was placed in rehabilitation in 2009 and placed in liquidation in March 2017. This expense does not directly relate to the underwriting or servicing of products for customers and is not directly related to the core performance of Aetna's business operations.
• Aetna recorded transaction and integration-related costs during the year ended December 31, 2017 primarily related to its proposed acquisition by CVS Health and its proposed acquisition of Humana (the "Humana Transaction"). Transaction costs include costs associated with the transactions contemplated by the merger agreement under which CVS Health Corporation has agreed to acquire all of Aetna's outstanding stock, the termination of the Humana Merger Agreement, the termination of Aetna's agreement to sell certain assets to Molina Healthcare, Inc. and advisory, legal and other professional fees which are reflected in Aetna's GAAP Consolidated Statements of Income in general and administrative expenses. Transaction costs also include the negative cost of carry associated with the debt financing that Aetna obtained in June 2016 for the Humana Transaction. Prior to the mandatory redemption of the SMR Notes, the negative cost of carry associated with these senior notes was excluded from pre-tax adjusted earnings. The negative cost of carry associated with the $2.8 billion aggregate principal amount of Aetna's senior notes issued in June 2016 that are not subject to mandatory redemption (the "Other 2016 Senior Notes") was excluded from pre-tax adjusted earnings through the date of the termination of the Humana Merger Agreement. The components of the negative cost of carry are reflected in Aetna's GAAP Consolidated Statements of Income in interest expense and net investment income. Subsequent to the termination of the Humana Merger Agreement, the interest expense and net investment income associated with the Other 2016 Senior Notes were no longer excluded from pre-tax adjusted earnings.
• Restructuring costs for the three months ended December 31, 2017 include severance costs associated with Aetna's expense management and cost control initiatives. The restructuring costs are reflected in Aetna's GAAP Consolidated Statements of Income in general and administrative expenses.
• In 1993, Aetna discontinued the sale of fully guaranteed large case pensions products and established a reserve for anticipated future losses on these products, which Aetna reviews quarterly. During the three months ended June 30, 2017, Aetna reduced the reserve for anticipated future losses on discontinued products. Aetna believes excluding any changes in the reserve for anticipated future losses on discontinued products from pre-tax adjusted earnings provides more useful information as to Aetna's continuing products and is consistent with the treatment of the operating results of these discontinued products, which are credited or charged to the reserve and do not affect Aetna's operating results.
• Other acquired intangible assets relate to Aetna's acquisition activities and are amortized over their useful lives. However, this amortization does not directly relate to the underwriting or servicing of products for customers and is not directly related to the core performance of Aetna's business operations.
• Net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of liabilities. However, these transactions do not directly relate to the underwriting or servicing of products for customers and are not directly related to the core performance of Aetna's business operations.

For a reconciliation of financial measures calculated under GAAP to these items, refer to the tables on pages 3 through 5 of this press release.

(2) Adjusted revenue excludes net realized capital gains and losses, gain related to the Group Insurance sale and interest income on the proceeds of Aetna's senior notes issued in June 2016 as noted in (1) above. Refer to the tables on pages 3 through 5 of this press release for a reconciliation of total revenue calculated under GAAP to adjusted revenue.

(3) Aetna's Corporate/Other category is not a business segment. It is added to Aetna's business segment to reconcile segment reporting to Aetna's consolidated results. The Corporate/Other category includes:

• Products for which Aetna no longer solicits or accepts new customers such as its large case pensions and long-term care products;
• Contracts Aetna has divested through reinsurance or other contracts, such as its domestic group life insurance, group disability insurance and absence management businesses; and
• Corporate expenses not supporting Aetna’s business operations, including transaction and integration-related costs, income taxes, interest expense on its outstanding debt and the financing components of its pension and other postretirement employee benefit plans expense.

As described in (1) above, the pre-tax adjusted earnings of the Corporate/Other category exclude other items, if any, that neither relate to the ordinary course of Aetna's business nor reflect Aetna's underlying business performance.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180417006586/en/

Aetna

Media Contact:

T.J. Crawford, 212-457-0583

[email protected]

or

Investor Contact:

Joe Krocheski, 860-273-0896

[email protected]

Source: Aetna

Press Releases